Literature DB >> 12192563

Carbon-11 tyrosine PET for visualization and protein synthesis rate assessment of laryngeal and hypopharyngeal carcinomas.

Jurjan R de Boer1, Bernard F A M van der Laan, Jan Pruim, Tjin H Que, Fred Burlage, Allard Krikke, Antoon T M Willemsen, Anton T M G Tiebosch, Frans W J Albers, Willem Vaalburg.   

Abstract

Accurate assessment of tumour extent and lymph node involvement in squamous cell carcinomas of the head and neck region is essential for therapy planning. Unfortunately, conventional diagnostic examination and imaging techniques, which monitor tumours on the basis of anatomical parameters, have drawbacks in clinical practice. The aim of this study was to investigate the feasibility of L-[1-(11)C]-tyrosine (TYR) positron emission tomography (PET) for visualisation of squamous cell carcinoma of the larynx and hypopharynx and quantification of tumour activity by assessment of protein synthesis rate (PSR). Dynamic TYR PET was performed on 31 patients with T1-T4 laryngeal or hypopharyngeal carcinoma before therapy. Plasma activity of TYR, (11)CO(2) and (11)C-protein levels were measured, and PSRs were calculated for primary malignancies. All 31 laryngeal and hypopharyngeal tumours were visualised as a hotspot (sensitivity 100%). The median PSR of the tumours (2.06 nmol ml(-1) min(-1); range 0.72-6.96) was significantly higher ( P<0.001) than that of non-tumour (background) tissue (0.51 nmol ml(-1) min(-1); range 0.22-0.89). L-[1-(11)C]-Tyrosine PET appears to be a potential method for visualisation of primary laryngeal and hypopharyngeal tumours. In vivo quantification of tumour activity by assessment of PSR is possible and may have a future role in the therapy planning and therapy evaluation of laryngeal and hypopharyngeal tumours.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12192563     DOI: 10.1007/s00259-002-0863-9

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  4 in total

1.  18F-FET PET/CT in advanced head and neck squamous cell carcinoma: an intra-individual comparison with 18F-FDG PET/CT.

Authors:  Stephan Kurt Haerle; Dorothee R Fischer; Daniel T Schmid; Nader Ahmad; Gerhard F Huber; Alfred Buck
Journal:  Mol Imaging Biol       Date:  2011-10       Impact factor: 3.488

Review 2.  Alternative PET tracers in head and neck cancer. A review.

Authors:  Jan Wedman; Jan Pruim; Jan L N Roodenburg; Gyorgy B Halmos; Johannes A Langedijk; Rudi A J O Dierckx; Bernard F A M van der Laan
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-12-27       Impact factor: 2.503

3.  Is C-11 Methionine PET an alternative to 18-F FDG-PET for identifying recurrent laryngeal cancer after radiotherapy?

Authors:  Jan Wedman; Jan Pruim; Lisa van der Putten; Otto S Hoekstra; Remco de Bree; Boukje A C van Dijk; Bernard F A M van der Laan
Journal:  Clin Otolaryngol       Date:  2018-11-18       Impact factor: 2.597

Review 4.  Imaging and cancer: a review.

Authors:  Leonard Fass
Journal:  Mol Oncol       Date:  2008-05-10       Impact factor: 7.449

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.